Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findings.
Rasmussen V, Forrest LE, Rogasik M, Girodet M, Meeus P, Sunyach MP, Blay JY, Bally O, Brahmi M, Ballinger ML, Niedermayr E, Thomas DM, Halliday J, James P, Ray-Coquard I, Young MA; International Sarcoma Kindred Study. Rasmussen V, et al. Among authors: girodet m. Per Med. 2018 Jan;15(1):13-24. doi: 10.2217/pme-2017-0035. Per Med. 2018. PMID: 29714116
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's).
Bétrian S, Bergeron C, Blay JY, Bompas E, Cassier PA, Chevallier L, Fayette J, Girodet M, Guillemet C, Le Cesne A, Marec-Berard P, Ray-Coquard I, Chevreau C. Bétrian S, et al. Among authors: girodet m. Clin Sarcoma Res. 2017 May 10;7:10. doi: 10.1186/s13569-017-0076-4. eCollection 2017. Clin Sarcoma Res. 2017. PMID: 28491276 Free PMC article.
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).
Penel-Page M, Ray-Coquard I, Larcade J, Girodet M, Bouclier L, Rogasik M, Corradini N, Entz-Werle N, Brugieres L, Domont J, Lervat C, Piperno-Neumann S, Pacquement H, Bay JO, Gentet JC, Thyss A, Chaigneau L, Narciso B, Cornille H, Blay JY, Marec-Bérard P. Penel-Page M, et al. Among authors: girodet m. BMC Cancer. 2015 Nov 5;15:854. doi: 10.1186/s12885-015-1894-5. BMC Cancer. 2015. PMID: 26541413 Free PMC article.
Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study.
Chvetzoff G, Girodet M, Despax J, Baudry V, Duranti J, Mastroianni B, Vanacker H, Vinceneux A, Brahmi M, Renard O, Gautier J, Britel M, Ducimetière F, Anota A, Cassier P, Christophe V. Chvetzoff G, et al. Among authors: girodet m. BMJ Open. 2022 Apr 22;12(4):e060317. doi: 10.1136/bmjopen-2021-060317. BMJ Open. 2022. PMID: 35459679 Free PMC article.
At the heart of the COVID-19 crisis: Perceived concerns of changes in long-term cancer care in French women with cancer.
Della Vecchia C, Girodet M, Ginguené S, Carpentier C, Leroy T, Siméone A, Vayre E, Mabire X, Ferraz D, Morin-Messabel C, Préau M. Della Vecchia C, et al. Among authors: girodet m. Eur J Cancer Care (Engl). 2022 Jul;31(4):e13599. doi: 10.1111/ecc.13599. Epub 2022 May 6. Eur J Cancer Care (Engl). 2022. PMID: 35523418 Free PMC article.
Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study.
Lochmann M, Girodet M, Despax J, Baudry V, Duranti J, Mastroianni B, Vanacker H, Vinceneux A, Brahmi M, Renard O, Verlingue L, Amini-Adle M, Swalduz A, Gautier J, Ducimetière F, Anota A, Cassier PA, Chvetzoff G, Christophe V. Lochmann M, et al. Among authors: girodet m. Support Care Cancer. 2024 May 15;32(6):353. doi: 10.1007/s00520-024-08535-x. Support Care Cancer. 2024. PMID: 38748187
13 results